Unless otherwise indicated, this Web Site and its contents are the property of Bionometrix Inc, a company registered in the United States of America. The copyright and all other intellectual property rights to the original material contained on this Web Site belongs to Bionometrix or its licensors.
This site also contains information and data which incorporate material contributed, sourced or licensed by individuals, companies, or organizations that may be protected by international copyright laws. Unless noted elsewhere, these include, but are not limited to, data that is from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine (NLM). NLM data are produced by a U.S. Government agency and include works of the United States Government that are not protected by U.S. copyright law but may be protected by non-US copyright law, as well as abstracts originating from publications that may be protected by U.S. and international copyright law. In addition, these works may include PubMed Central (PMC) (see PMC Copyright Notice), Bookshelf (see Bookshelf Copyright Notice), and OMIM (see OMIM Copyright Status). All persons reproducing, redistributing, or making commercial use of this information are expected to adhere to the terms and conditions asserted by the copyright holder(s). Transmission or reproduction of protected items beyond that allowed by fair use as defined in the copyright laws requires the written permission of the copyright owners.
Information that was created by or for the government of the United States of America on this site is within the public domain. Public domain information on the National Library of Medicine (NLM) Web pages may be freely distributed and copied. However, it is requested that in any subsequent use of this work, NLM be given appropriate acknowledgment.
Information in this web site may contain data and/or references may be made to data from different collections of biomedical data, which may have copyright restrictions under international law or have Creative Commons Attribution, and include, but are not limited to:
Forbes, S.A., et al. (2011) COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer, Nucleic Acids Res, 39, D945-950.
Zang, Z.J., et al. (2011) Genetic and structural variation in the gastric cancer kinome revealed through targeted deep sequencing, Cancer Res, 71, 29-39.
Timmermann, B., et al. (2010) Somatic mutation profiles of MSI and MSS colorectal cancer identified by whole exome next generation sequencing and bioinformatics analysis, PLoS One, 5, e15661.
Meyerson, M., Gabriel, S. and Getz, G. (2010) Advances in understanding cancer genomes through second-generation sequencing, Nat Rev Genet, 11, 685-696.
Robison, K. (2010) Application of second-generation sequencing to cancer genomics, Brief Bioinform, 11, 524-534.
Amberger, J., Bocchini, C.A., Scott, A.F. and Hamosh, A. (2009) McKusick's Online Mendelian Inheritance in Man (OMIM). Nucleic Acids Res, 37, D793-796.
UniProt consortium (2009) The Universal Protein Resource (UniProt) 2009. Nucleic Acids Res, 37, D169-174.
Thomas, R.K., et al. (2007) High-throughput oncogene mutation profiling in human cancer, Nat Genet, 39, 347-351.
Futreal, P.A., et al. (2004) A census of human cancer genes, Nat Rev Cancer, 4, 177-183.
Cancer Gene Index of National Cancer Institute (https://cabig.nci.nih.gov)
NCBI Entrez gene site (http://www.ncbi.nlm.nih.gov/gene)
Bionometrix has adopted the following general policy toward copyright infringement in accordance with the Digital Millennium Copyright Act of the United States of America. The address of the Designated Agent to Receive Notification of Claimed Infringement (“Designated Agent”) is listed at the end of this policy.
If you believe any materials accessible on this web site infringes your copyright, you may request removal of those materials (or access thereto) from the Services by contacting our Customer Support and providing the following information:
Identification of the copyrighted work that you believe to be infringed. Please describe the work, and where possible include a copy or the location (e.g., URL) of an authorized version of the work.
Identification of the material that you believe to be infringing and its location. Please describe the material, and provide us with its URL or any other pertinent information that will allow us to locate the material.
Your name, address, telephone number and (if available) e-mail address.
A statement that you have a good faith belief that the complained of use of the materials is not authorized by the copyright owner, its agent, or the law.
A statement that the information that you have supplied is accurate, and indicating that “under penalty of perjury,” you are the copyright owner or are authorized to act on the copyright owner’s behalf.
A signature or the electronic equivalent from the copyright holder or authorized representative.
In an effort to protect the rights of copyright owners, we maintain a policy for the termination, in appropriate circumstances, of subscribers and account holders who are repeat infringers.
Please contact our Designated Agent to Receive Notification of Claimed Infringement at Customer Support, or at: